BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 12764355)

  • 1. Complete remission induced by G-CSF in a patient with acute myeloid leukemia with t(8;21)(q22;q22).
    Ferrara F; Schiavone EM; Palmieri S; Mele G; Pocali B; Scalia G; Morabito P; Sebastio L; Del Vecchio L
    Hematol J; 2003; 4(3):218-21. PubMed ID: 12764355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complete remission in acute myeloid leukemia with granulocyte-colony stimulating factor without chemotherapy. Report of cytogenetic remission of a t(9;11)(p22q23) positive AML patient and review of literature.
    Piccaluga PP; Martinelli G; Malagola M; Rondoni M; Bianchini M; Visani G; Baccarani M
    Haematologica; 2003 Aug; 88(8):ECR28. PubMed ID: 12935987
    [No Abstract]   [Full Text] [Related]  

  • 3. Complete remission in acute myeloid leukaemia with t(8;21) following treatment with G-CSF: flow cytometric analysis of in vivo and in vitro effects on cell maturation.
    Ferrara F; Di Noto R; Viola A; Russo C; Boccuni P; Costantini S; Dello Russo A; Lo Pardo C; Del Vecchio L
    Br J Haematol; 1999 Aug; 106(2):520-3. PubMed ID: 10460615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. t(8;21) (q22;q22) acute myelogenous leukemia in Mexico: a single institution experience.
    Ruiz-Argüelles GJ; Morales-Toquero A; Manzano C; Ruiz-Delgado GJ; Jaramillo P; Gonzalez-Carrillo ML; Reyes-Núñez V
    Hematology; 2006 Aug; 11(4):235-8. PubMed ID: 17178661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the neural cell adhesion molecule CD56 is associated with short remission duration and survival in acute myeloid leukemia with t(8;21)(q22;q22).
    Baer MR; Stewart CC; Lawrence D; Arthur DC; Byrd JC; Davey FR; Schiffer CA; Bloomfield CD
    Blood; 1997 Aug; 90(4):1643-8. PubMed ID: 9269784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. t(3;21)(q26;q22) in myeloid leukemia: an aggressive syndrome of blast transformation associated with hydroxyurea or antimetabolite therapy.
    Yin CC; Cortes J; Barkoh B; Hayes K; Kantarjian H; Jones D
    Cancer; 2006 Apr; 106(8):1730-8. PubMed ID: 16532439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose cytarabine, idarubicin, and granulocyte colony-stimulating factor remission induction therapy for previously untreated de novo and secondary adult acute myeloid leukemia.
    Baer MR; Christiansen NP; Frankel SR; Brunetto VL; Mrózek K; Bloomfield CD; Herzig GP
    Semin Oncol; 1993 Dec; 20(6 Suppl 8):6-12. PubMed ID: 7507264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics and prognostic factors of acute myeloid leukemia with t (8; 21) (q22; q22).
    Lai YY; Qiu JY; Jiang B; Lu XJ; Huang XJ; Zhang Y; Liu YR; Shi HL; Lu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Oct; 13(5):733-40. PubMed ID: 16277833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute myeloid leukemia with a RUNX1-RUNX1T1 t(1;21;8)(q21;q22;q22) novel variant: a case report and review of the literature.
    Kim H; Moon HW; Hur M; Yun YM; Lee MH
    Acta Haematol; 2011; 125(4):237-41. PubMed ID: 21325813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orbital tumor in acute myeloid leukemia associated with karyotype 46,XX,t(8;21)(q22;q22): a case report.
    Tanigawa M; Tsuda Y; Amemiya T; Yamada K; Nakayama M; Tsuji Y
    Ophthalmologica; 1998; 212(3):202-5. PubMed ID: 9562099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid engraftment after autologous transplantation utilizing marrow and recombinant granulocyte colony-stimulating factor-mobilized peripheral blood stem cells in patients with acute myelogenous leukemia.
    Demirer T; Buckner CD; Appelbaum FR; Petersen FB; Rowley S; Weaver CH; Lilleby K; Sanders J; Chauncey T; Storb R
    Bone Marrow Transplant; 1995 Jun; 15(6):915-22. PubMed ID: 7581091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of t(8;21) acute myeloid leukemia (AML) with additional chromosomal abnormality: concomitant trisomy 4 may constitute a distinctive subtype of t(8;21) AML.
    Nishii K; Usui E; Katayama N; Lorenzo F; Nakase K; Kobayashi T; Miwa H; Mizutani M; Tanaka I; Nasu K; Dohy H; Kyo T; Taniwaki M; Ueda T; Kita K; Shiku H
    Leukemia; 2003 Apr; 17(4):731-7. PubMed ID: 12682630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The detection of flow cytometric G-CSF receptor expression and it's effect on therapy in acute myeloid leukemia.
    Kutlay S; Beksac M; Dalva K; Ilhan O; Koc H; Akan H; Ozcan M
    Leuk Lymphoma; 2003 May; 44(5):791-5. PubMed ID: 12802915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remission induction by granulocyte colony-stimulating factor in hypoplastic acute myelogenous leukemia complicated by infection. A case report and review of the literature.
    Takamatsu Y; Miyamoto T; Iwasaki H; Makino S; Tamura K
    Acta Haematol; 1998; 99(4):224-30. PubMed ID: 9644302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical analysis of acute myeloid leukemia with t(8;21) (q22;q22) and loss of Y chromosome].
    Zhu CY; Yang H; Niu JH; Zhang Q; Xie XL; Wang LJ; Zhu HY; Yao ZL; Yu L; Jing Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):950-6. PubMed ID: 25130809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complete remission in hypoplastic acute myeloid leukemia induced by G-CSF without chemotherapy: report on three cases.
    Nimubona S; Grulois I; Bernard M; Drénou B; Godard M; Fauchet R; Lamy T
    Leukemia; 2002 Sep; 16(9):1871-3. PubMed ID: 12200710
    [No Abstract]   [Full Text] [Related]  

  • 17. High remission rate, short remission duration in patients with refractory anemia with excess blasts (RAEB) in transformation (RAEB-t) given acute myelogenous leukemia (AML)-type chemotherapy in combination with granulocyte-CSF (G-CSF).
    Estey EH; Kantarjian HM; O'Brien S; Kornblau S; Andreeff M; Beran M; Pierce S; Keating M
    Cytokines Mol Ther; 1995 Mar; 1(1):21-8. PubMed ID: 9384660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Timed-sequential chemotherapy with concomitant granulocyte colony-stimulating factor for newly diagnosed de novo acute myelogenous leukemia.
    He XY; Pohlman B; Lichtin A; Rybicki L; Kalaycio M
    Leukemia; 2003 Jun; 17(6):1078-84. PubMed ID: 12764371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salvage chemotherapy with low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor priming in patients with refractory or relapsed acute myeloid leukemia with translocation (8;21).
    Wang Y; Li W; Chen S; Qiu H; Sun A; Wu D
    Leuk Res; 2011 May; 35(5):604-7. PubMed ID: 21130493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute myeloid leukemia with translocation (8;21) or inversion (16) in elderly patients treated with conventional chemotherapy: a collaborative study of the French CBF-AML intergroup.
    Prébet T; Boissel N; Reutenauer S; Thomas X; Delaunay J; Cahn JY; Pigneux A; Quesnel B; Witz F; Thépot S; Ugo V; Terre C; Recher C; Tavernier E; Hunault M; Esterni B; Castaigne S; Guilhot F; Dombret H; Vey N; ; ;
    J Clin Oncol; 2009 Oct; 27(28):4747-53. PubMed ID: 19720919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.